标题
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
作者
关键词
-
出版物
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-10-01
DOI
10.1007/s13318-019-00577-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2019) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-drug interaction (DDI) of darolutamide with cytochrome P450 (CYP) and P-glycoprotein (P-gp) substrates: Results from clinical and in vitro studies.
- (2019) Christian Zurth et al. JOURNAL OF CLINICAL ONCOLOGY
- Higher blood–brain barrier penetration of [14C]apalutamide and [14C]enzalutamide compared to [14C]darolutamide in rats using whole-body autoradiography.
- (2019) Christian Zurth et al. JOURNAL OF CLINICAL ONCOLOGY
- Food Effect on Rosuvastatin Disposition and Low-Density Lipoprotein Cholesterol
- (2018) Cheynne C. McLean et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Blood-brain barrier penetration of [14C]darolutamide compared with [14C]enzalutamide in rats using whole body autoradiography.
- (2018) Christian Zurth et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer
- (2018) Karim Fizazi et al. Clinical Genitourinary Cancer
- The Combination of Enzalutamide and Opioids: A Painful Pitfall?
- (2018) Guillemette E. Benoist et al. EUROPEAN UROLOGY
- Cancer-Related Fatigue
- (2017) Ann M. Berger et al. Journal of the National Comprehensive Cancer Network
- Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A
- (2016) T Prueksaritanont et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study
- (2016) Christophe Massard et al. EUROPEAN UROLOGY
- Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3
- (2015) Wendy P. Battisti et al. ANNALS OF INTERNAL MEDICINE
- Pharmacokinetic Drug Interaction Studies with Enzalutamide
- (2015) Jacqueline A. Gibbons et al. CLINICAL PHARMACOKINETICS
- Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies
- (2015) Anu-Maarit Moilanen et al. Scientific Reports
- Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin
- (2014) Thomayant Prueksaritanont et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now